Clinical Trials on Scales, Repression-Sensitization in Japan

Total 84 results

Santen Pharmaceutical Co., Ltd.

Completed

Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers

Healthy Adult Males Volunteers

Japan
Takeda

Completed

A Bioequivalence Study of TAK-536 Pediatric Formulation

Japanese Healthy Adult Males

Japan
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of TAS3731 in Healthy Adults

Healthy Adult Males

Japan
Takeda

Completed

Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam

Japanese Healthy Adult Males

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males

Healthy Adult Males

Japan
Gunma University

Completed

Treating Depressed Mood With a Smartphone-delivered Positive Word Stimulation for Subthreshold Depression

Subthreshold Depression

Japan
Kibi International University

Completed

Smartphone Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Kibi International University

Completed

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Bristol-Myers Squibb

Completed

Japanese Phase 1 Multiple Ascending Dose (MAD) Study

Depression

Japan
Shionogi
Eli Lilly and Company

Terminated

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
University of Jazan
Saudi Board of Community Medicine

Completed

Effects of an Educational Program on Depression Literacy and Stigma Among Secondary School Students in Jazan City

Depression Literacy | Depression Stigma

Saudi Arabia
Shionogi
Eli Lilly and Company

Completed

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
Kibi International University

Unknown

iPad Application-based Intervention for Post-stroke Depression

Post-stroke Depression

Japan
Astellas Pharma Inc

Completed

Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Bipolar Depression

Japan
Kyoto University
Nagoya City University

Completed

Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace

Depression

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Kyoto University
National Center of Neurology and Psychiatry, Japan

Completed

Strategic Use of New Generation Antidepressants for Depression (SUN(^_^)D)

Unipolar Major Depressive Episode

Japan
Chiba University

Completed

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

Adolescent | Depression

Japan
Astellas Pharma Inc

Completed

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Kyorin University

Completed

MicroRNA Expression in Human Blood Serum and Vitreous Body

MicroRNA Expression Profile in Human Vitreous

Japan
Astellas Pharma Inc

Completed

Oral Multiple-dose Study in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Showa University

Completed

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder (AFADTRMDD)

Major Depressive Disorder

Japan
Nagoya City University

Completed

Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression

Major Depressive Disorder

Japan
Oizumi Hospital

Unknown

Benefits of Switching Antidepressants Following Early Nonresponse

Depression

Japan
Astellas Pharma Inc

Completed

Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder

Major Depressive Disorder

Japan
Astellas Pharma Inc

Completed

Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

Major Depressive Disorder Patients

Japan
Astellas Pharma Inc

Completed

Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

Major Depressive Disorder Patients

Japan
Tokyo Medical University
University of Toyama; China Medical University, Taiwan; Chiba University; Japan...

Completed

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial

Depression | Pregnancy

Taiwan, Japan
Kyorin University

Completed

MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy

MicroRNA Expression Profile in Human Vitreous of Various Vitreoretinal Diseases

Japan
GlaxoSmithKline

Completed

Study Of 323U66 SR In Major Depressive Disorder

Depressive Disorder

Japan
Tokyo Medical University
University of Toyama; China Medical University, Taiwan; Chiba University; Japan... and other collaborators

Completed

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)

Depression | Pregnancy

Japan, Taiwan
National Center of Neurology and Psychiatry, Japan

Terminated

Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research (ADAPT)

Depression | Alzheimer Disease

Japan
Shiga University
Merck Sharp & Dohme LLC; Koka city

Unknown

Night in Japan Home Sleep Monitoring Study (NinJaSleep)

Depression | Sleep Initiation and Maintenance Disorders

Japan
Nagoya City University
Kochi University

Completed

Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia

Major Depressive Disorder

Japan
Sumitomo Pharma Co., Ltd.

Completed

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Bipolar Depression

Lithuania, Malaysia, Russian Federation, Slovakia, Ukraine, Japan, Philippines, Taiwan
GlaxoSmithKline

Completed

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Major Depressive Disorder (MDD)

Japan
Eli Lilly and Company

Completed

A Study of LY2216684 in Participants With Major Depression Disorder

Major Depressive Disorder

Japan
Novartis Pharmaceuticals

Completed

Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Treatment-Resistant Depression

Spain, Japan, Poland, United States
GlaxoSmithKline

Terminated

Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

Depressive Disorder

Japan
GlaxoSmithKline

Completed

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

Depressive Disorder

Japan
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Takeda

Completed

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Insomnia | Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Major Depressive Disorder

Japan
Pfizer

Completed

Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)

Major Depressive Disorder

Japan
Medtronic - MITG

Completed

PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY (PRODIGY)

Respiratory Depression

United States, Japan, Spain, Singapore, Germany, Netherlands, France
Eli Lilly and Company

Completed

Olanzapine Treatment of Patients With Bipolar I Disorder

Depression, Bipolar

China, Korea, Republic of, Japan

3

Subscribe